Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger

J&M Shuler

Status and phase

Unknown

Phase 3

Conditions

Stenosing Tenosynovitis

Treatments

Biological: Amniotic fluid injection

Biological: Steroid injection

Study type

Interventional

Funder types

Industry

Other

Identifiers

NCT03583151

Random TF

Details and patient eligibility

About

The proposed study aims to investigate whether amniotic fluid injections are a better alternative to corticosteroid injections as a conservative treatment for stenosing tenosynovitis. Based on results from our most recent pilot study exploring patient outcomes after receiving an amnion injection, we were able to observe symptom resolution in more than half of the study population. Adverse events were extremely rare and not related to study participation. Given the numerous occurrences of successful symptom resolution, the next step is to compare patient outcomes to those of patients who receive the standard steroid injection. This study will compare outcome measurements of patients who receive amnion injections to those who receive steroid injections.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient is at least 18 years of age
Patient is diagnosed with stenosing tenosynovitis

Exclusion criteria

Patient is less than 18 years of age
Pregnancy
Enrolling clinician does not believe that the patient is mentally capable of understanding the research nature of the procedure due to mental handicap/disability or illiteracy.